1. Home
  2. SFNC vs QURE Comparison

SFNC vs QURE Comparison

Compare SFNC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simmons First National Corporation

SFNC

Simmons First National Corporation

N/A

Current Price

$23.36

Market Cap

3.3B

Sector

Finance

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$23.83

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SFNC
QURE
Founded
1903
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
SFNC
QURE
Price
$23.36
$23.83
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$26.07
★ $60.37
AVG Volume (30 Days)
1.8M
★ 2.3M
Earning Date
10-15-2026
11-09-2026
Dividend Yield
★ 3.69%
N/A
EPS Growth
N/A
★ 29.67
EPS
★ 0.93
N/A
Revenue
N/A
★ $13,107,000.00
Revenue This Year
$10.72
$54.78
Revenue Next Year
$2.97
$356.14
P/E Ratio
$25.10
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$17.00
$8.73
52 Week High
$24.32
$70.88

Technical Indicators

Market Signals
Indicator
SFNC
QURE
Relative Strength Index (RSI) 61.89 36.59
Support Level $23.33 $22.32
Resistance Level $24.10 $25.61
Average True Range (ATR) 0.46 1.20
MACD 0.15 0.86
Stochastic Oscillator 87.19 90.45

Price Performance

Historical Comparison
SFNC
QURE

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. Its loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: